IP Library Granted Patent US 8,528,563
Granted Patent B2
US 8,528,563 · App. 12/098,224 · Granted Sep 10, 2013

Systems, methods and devices for performing gynecological procedures

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,528,563
App. No.
12/098,224
Granted
Sep 10, 2013
Kind
B2
Abstract

Systems, methods, apparatus and devices for performing improved gynecologic and urologic procedures are disclosed. The system and devices provide simplified use and reduced risk of adverse events. Patient benefit is achieved through improved outcomes, reduced pain, especially peri-procedural pain, and reduced recovery times. The various embodiments enable procedures to be performed outside the hospital setting, such as in a doctor's office or clinic.

Claims (22)

1. A fallopian tube occlusion device, comprising:

an apical hub dimensioned for endolumenal navigation into a fallopian tube; and

at least three corrugated arms having respective proximal ends joined together at the apical hub, each arm comprising a unidirectional corrugated segment extending in a distal direction away from the apical hub, the arms movable from a substantially parallel, low profile configuration to an inclined, radially enlarged configuration, in which respective distal ends of the arms are flared apart from one another while the proximal ends remain joined together at the apical hub, each arm further comprising a distal end tissue anchor,

wherein the corrugated arms are biased in the direction of the radially enlarged configuration, and

wherein at least one of the arms comprises a locking barb, and wherein the device further comprises a containment ring configured to be advanced over the arms from a location adjacent to the apical hub to a location beyond the locking barb.

2. The fallopian tube occlusion device as in claim 1 , wherein at least a portion of the device comprises copper.

3. The fallopian tube occlusion device as in claim 2 , wherein the arms comprise copper.

4. The fallopian tube occlusion device as in claim 1 , wherein the tissue anchors comprise hooks, each hook having a distal tip portion forming an acute angle with the respective arm.

5. The fallopian tube occlusion device as in claim 4 , the hooks comprising an up or down orientation that is alternated with each arm.

6. The fallopian tube occlusion device as in claim 1 , further comprising a microporous membrane to prevent an egg from progressing into a uterus and to prevent sperm from entering the fallopian tube.

7. The fallopian tube occlusion device as in claim 1 , the device having an outer diameter configured to allow the fallopian tube occlusion device to be delivered through a catheter having a diameter less than 3 mm when the arms are in the low profile configuration.

8. A fallopian tube occlusion device, comprising:

an apical hub dimensioned for endolumenal navigation into a fallopian tube;

at least three arms having respective proximal ends joined together at the apical hub, the arms extending in a distal direction away from the apical hub and movable from a substantially parallel, low profile configuration to an inclined, radially enlarged configuration, in which respective distal ends of the arms are flared apart from one another while the proximal ends remain joined together at the apical hub, each arm further comprising a distal end; and

a containment ring configured to be advanced over the arms in a distal direction away from the apical hub to gather the arms when the tissue anchors have engaged an inner wall of a fallopian tube, so that the device substantially occludes the fallopian tube.

9. The fallopian tube occlusion device as in claim 8 , wherein the arms are corrugated, each arm comprising a unidirectional corrugated segment.

10. The fallopian tube occlusion device as in claim 8 , the containment ring configured to be attached to a stiffening rod coupled to a delivery catheter.

11. The fallopian tube occlusion device as in claim 8 , wherein the arms are biased in the direction of the radially enlarged configuration.

12. The fallopian tube occlusion device as in claim 8 , wherein at least a portion of the device comprises copper.

13. The fallopian tube occlusion device as in claim 8 , wherein the tissue anchors comprise hooks, and wherein each hook has a recurved base.

14. The fallopian tube occlusion device as in claim 13 , wherein the hooks comprising an up or down orientation that is alternated with each arm.

15. The fallopian tube occlusion device as in claim 8 , wherein at least one of the arms comprises a locking barb, and wherein the containment ring is configured to be advanced over the arms from a location adjacent to the apical hub to a location beyond the locking barb.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 18, 2011
From: INTERLACE MEDICAL, INC.
To: HOLOGIC, INC.
Reel/Frame 025835/0684 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 8, 2009
From: GRUBER, WILLIAM HARWICK
To: INTERLACE MEDICAL, INC.
Reel/Frame 022665/0961 →